FOLFOXA

DRUG3 trials

Sponsors

Brown University

Conditions

Locally Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Cancer

Phase 2

BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

CompletedNCT02022033

Brown UniversityPancreatic Cancer

Start: 2014-02-01End: 2022-03-17Updated: 2022-06-01

BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

CompletedNCT02080221

Brown UniversityMetastatic Pancreatic Cancer

Start: 2014-08-31End: 2022-03-16Updated: 2022-08-01

FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

CompletedNCT02578732

Brown UniversityLocally Advanced Pancreatic Cancer, Pancreatic Cancer

Start: 2016-07-12End: 2022-03-16Updated: 2023-05-06

Related Papers

Adjuvant FOLFOX + nab-paclitaxel (FOLFOX-A)for pancreatic cancer, BrUOG 278: A Brown University oncology research group phase II study.

Journal of Clinical Oncology2019-05-20

Toxicity of FOLFOX-abraxane (FOLFOX-A) on phase II Brown University Oncology Group (BrUOG) trials.

Journal of Clinical Oncology2019-01-292 citations

Adjuvant FOLFOX-Nab-paclitaxel (FOLFOX-A) for pancreatic cancer: A phase II Brown University Oncology Research Group (BrUOG) trial.

Journal of Clinical Oncology2018-02-01